×
S&P 500   3,825.33
DOW   31,097.26
QQQ   282.13
S&P 500   3,825.33
DOW   31,097.26
QQQ   282.13
S&P 500   3,825.33
DOW   31,097.26
QQQ   282.13
S&P 500   3,825.33
DOW   31,097.26
QQQ   282.13
NASDAQ:AVDL

Avadel Pharmaceuticals News Headlines

$2.57
+0.13 (+5.33%)
(As of 07/1/2022 12:00 AM ET)
Add
Compare
Today's Range
$2.37
$2.57
50-Day Range
$1.07
$5.30
52-Week Range
$1.05
$11.59
Volume
521,881 shs
Average Volume
2.19 million shs
Market Capitalization
$151.73 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$9.25
Get Avadel Pharmaceuticals News Delivered to You Automatically

Sign up to receive the latest news and ratings for AVDL and its competitors with MarketBeat's FREE daily newsletter.

AVDL Media Mentions By Week

AVDL Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

AVDL
News Sentiment

1.02

0.77

Average
Medical
News Sentiment

AVDL News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

AVDL Articles
This Week

6

1

AVDL Articles
Average Week



AVDL Stock News Headlines Today

SourceHeadline
marketbeat.com logoHC Wainwright Reaffirms Buy Rating for Avadel Pharmaceuticals (NASDAQ:AVDL)
marketbeat.com - July 1 at 12:18 PM
seekingalpha.com logoAvadel rises 18% as it expects tentative approval for sleep disorder drug; expects final approval by June 2023
seekingalpha.com - June 29 at 8:08 PM
finance.yahoo.com logoAvadel Pharmaceuticals Provides Corporate Update
finance.yahoo.com - June 29 at 8:08 PM
finance.yahoo.com logoAvadel Pharmaceuticals and the American Academy of Sleep Medicine Foundation Announce an Exclusive Collaboration on the 2022 Young Investigators Research Forum
finance.yahoo.com - June 3 at 12:59 PM
finance.yahoo.com logoAvadel Pharmaceuticals to Present at the Jefferies Healthcare Conference
finance.yahoo.com - June 2 at 11:57 AM
finance.yahoo.com logoThomas McHugh Is The Senior VP & CFO of Avadel Pharmaceuticals plc (NASDAQ:AVDL) And They Just Picked Up 233% More Shares
finance.yahoo.com - June 2 at 6:57 AM
seekingalpha.com logoAvadel Pharmaceuticals reports insider transactions from Director, CEO & CFO
seekingalpha.com - June 1 at 3:55 PM
seekingalpha.com logoAvadel spikes as Oppenheimer says selloff is overdone
seekingalpha.com - May 27 at 10:48 AM
markets.businessinsider.com logoMid-Day Market Update: Crude Oil Jumps Over 3%; NRx Pharmaceuticals Shares Tumble
markets.businessinsider.com - May 26 at 1:05 PM
finance.yahoo.com logoAvadel's stock falls 21% after disclosing new FDA request for experimental narcolepsy drug
finance.yahoo.com - May 26 at 1:05 PM
finance.yahoo.com logoAvadel to Present Clinical Data for FT218 at SLEEP 2022
finance.yahoo.com - May 19 at 5:47 PM
finance.yahoo.com logoAvadel Pharmaceuticals to Present at the H.C. Wainwright Global Investment Conference
finance.yahoo.com - May 18 at 9:43 AM
seekingalpha.com logoAvadel Pharmaceuticals plc (AVDL) CEO Gregory Divis on Q1 2022 Results - Earnings Call Transcript
seekingalpha.com - May 9 at 5:32 PM
nz.finance.yahoo.com logoAvadel Pharmaceuticals Provides Corporate Update and Reports First Quarter 2022 Financial Results
nz.finance.yahoo.com - May 9 at 7:31 AM
seekingalpha.com logoAvadel Pharmaceuticals GAAP EPS of -$0.45 misses by $0.02
seekingalpha.com - May 9 at 7:31 AM
finance.yahoo.com logoAvadel Pharmaceuticals Provides Corporate Update and Reports First Quarter 2022 Financial Results
finance.yahoo.com - May 9 at 7:31 AM
finance.yahoo.com logoAvadel Pharmaceuticals to Provide a Corporate Update and Report First Quarter Financial Results on May 9
finance.yahoo.com - May 2 at 10:23 AM
finance.yahoo.com logoWhy Avadel Pharmaceuticals Stock Is Skyrocketing Today
finance.yahoo.com - April 26 at 2:59 PM
seekingalpha.com logoAvadel shares surge as company comments on recent trading activity
seekingalpha.com - April 26 at 9:58 AM
finance.yahoo.com logoAvadel Pharmaceuticals Provides Comment on Recent Trading Activity
finance.yahoo.com - April 26 at 9:58 AM
seekingalpha.com logoAvadel reports publication of data showing benefits of sleep disorder drug FT218
seekingalpha.com - April 6 at 7:16 PM
finance.yahoo.com logoAvadel Pharmaceuticals Announces Publication of Positive Secondary Endpoint Data from Pivotal Phase 3 REST-ON Trial
finance.yahoo.com - April 6 at 9:08 AM
seekingalpha.com logoAvadel Pharmaceuticals GAAP EPS of -$0.38 beats by $0.03
seekingalpha.com - March 17 at 7:09 PM
finance.yahoo.com logoAvadel Pharmaceuticals Provides Corporate Update and Reports Fourth Quarter and Full Year 2021 Financial Results
finance.yahoo.com - March 17 at 7:09 PM
benzinga.com logoEarnings Preview: Avadel Pharmaceuticals
benzinga.com - March 16 at 6:30 PM
finance.yahoo.com logoAvadel Pharmaceuticals Announces Appointment of Brandi Robinson as Senior Vice President, Corporate Affairs
finance.yahoo.com - March 14 at 7:26 PM
finance.yahoo.com logoAvadel Pharmaceuticals to Provide a Corporate Update and Report Fourth Quarter and Full Year 2021 Financial Results on March 17th
finance.yahoo.com - March 14 at 9:24 AM
seekingalpha.com logoAvadel posts new efficacy and safety data for lead candidate in narcolepsy
seekingalpha.com - March 11 at 10:11 AM
finance.yahoo.com logoAvadel Announces New Positive Data for Once-at-Bedtime FT218 for Narcolepsy and Once-Nightly Dosing Preference Among Patients and Clinicians at World Sleep 2022
finance.yahoo.com - March 11 at 10:10 AM
finance.yahoo.com logoAvadel Pharmaceuticals to Present at the Oppenheimer 32nd Annual Healthcare Conference
finance.yahoo.com - March 10 at 7:09 PM
finance.yahoo.com logoIs Avadel Pharmaceuticals (NASDAQ:AVDL) A Risky Investment?
finance.yahoo.com - February 22 at 12:48 PM
finance.yahoo.com logoAvadel Pharmaceuticals to Present at the 11th Annual SVB Leerink Global Healthcare Conference
finance.yahoo.com - February 10 at 12:15 PM
finance.yahoo.com logoDo Options Traders Know Something About Avadel (AVDL) Stock We Don't?
finance.yahoo.com - December 8 at 1:39 PM
finance.yahoo.com logoAvadel Pharmaceuticals to Present at Upcoming Investor Conferences in November
finance.yahoo.com - November 9 at 8:50 AM
finance.yahoo.com logoAvadel Pharmaceuticals plc (AVDL) Q3 2021 Earnings Call Transcript
finance.yahoo.com - November 8 at 5:49 PM
finance.yahoo.com logoAvadel Pharmaceuticals Provides Corporate Update and Reports Third Quarter 2021 Financial Results
finance.yahoo.com - November 8 at 12:48 PM
nasdaq.com logoHere's What Avadel Pharmaceuticals plc's (NASDAQ:AVDL) Shareholder Ownership Structure Looks Like
nasdaq.com - November 6 at 1:34 PM
finance.yahoo.com logoAvadel Pharmaceuticals to Provide a Corporate Update and Report Third Quarter 2021 Financial Results on November 8th
finance.yahoo.com - November 1 at 8:26 AM
finance.yahoo.com logoAvadel Presents New Data Supporting Clinical Benefit with Once-at-Bedtime FT218 and Preference for Once-Nightly Dosing in Patients with Narcolepsy at CHEST 2021
finance.yahoo.com - October 19 at 8:25 AM
finance.yahoo.com logoSHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Avadel Pharmaceuticals plc - AVDL
finance.yahoo.com - October 18 at 10:23 PM
baystreet.ca logoAvadel Gets FDA Nod, Shares Decline
baystreet.ca - October 18 at 12:22 PM
benzinga.com logoAvadel Shares Fall As FDA Pushes Approval For Its Narcolepsy Treatment Candidate
benzinga.com - October 18 at 8:30 AM
markets.businessinsider.com logoPre-market Movers: JCS, VALN, RVNC, HX, AVDL…
markets.businessinsider.com - October 18 at 7:19 AM
markets.businessinsider.com logoAvadel : FDA's Review Of NDA Of FT218 On Narcolepsy Still Ongoing, No Action Taken In October
markets.businessinsider.com - October 15 at 10:39 PM
finance.yahoo.com logoAvadel Pharmaceuticals Announces Ongoing FDA Review of NDA for FT218 for Patients with Narcolepsy
finance.yahoo.com - October 15 at 8:30 PM
benzinga.com logoThinking about buying stock in Protagonist Therapeutics, Flexion Therapeutics, Avadel Pharmaceuticals, US Well Services, or Magnolia Oil & Gas?
benzinga.com - October 13 at 10:23 AM
markets.businessinsider.com logoPre-market Movers: TRVI, NTRB, LQDA, CEI, AVDL…
markets.businessinsider.com - October 11 at 7:08 AM
finance.yahoo.com logoImplied Volatility Surging for Avadel (AVDL) Stock Options
finance.yahoo.com - September 29 at 7:49 PM
finance.yahoo.com logoAvadel Recognizes World Narcolepsy Day and Announces New Data Presentations from Pivotal Phase 3 REST-ON Trial of FT218 at Upcoming Conference
finance.yahoo.com - September 20 at 8:56 AM
finance.yahoo.com logoAVDL Sep 2021 5.000 call
finance.yahoo.com - September 18 at 8:07 AM
finance.yahoo.com logoAvadel Pharmaceuticals to Present at Upcoming Investor Conferences
finance.yahoo.com - September 2 at 9:37 AM
Get Avadel Pharmaceuticals News Delivered to You Automatically

Sign up to receive the latest news and ratings for AVDL and its competitors with MarketBeat's FREE daily newsletter.

This page (NASDAQ:AVDL) was last updated on 7/2/2022 by MarketBeat.com Staff

MarketBeat Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer.